Status:
NOT_YET_RECRUITING
Investigating Participation Patterns Among Stage IV Melanoma Patients
Lead Sponsor:
Power Life Sciences Inc.
Conditions:
Stage IV Melanoma
Eligibility:
All Genders
18+ years
Brief Summary
Clinical trials, specifically focused on stage IV melanoma, are crucial in assessing the safety and efficacy of new treatments for this disease. These trials serve as fundamental instruments in determ...
Eligibility Criteria
Inclusion
- Aged ≥ 18 years old
- Diagnosis of stage IV melanoma
- Able to comprehend the investigational nature of the protocol and provide informed consent
Exclusion
- Female patients who are currently pregnant or nursing
- Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
- Inability to perform regular electronic reporting
Key Trial Info
Start Date :
November 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 1 2026
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06093594
Start Date
November 1 2024
End Date
November 1 2026
Last Update
October 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Power Life Sciences
San Francisco, California, United States, 94107